SCBIO is a pharmaceutical company focusing on making drugs to improve wellbeing by allowing accessible medicines to all patients in needs with highly specialized technologies in immuno-oncology.
The vision of the company lay in utilizing cutting edge technologies.
With sophisticated and precise technologies, we discover and develop novel therapeutics leading innovations for future medicine.
Utilizing our technological capabilities enables SCBIO team the ability, to apply cutting edge technologies,
to offer smart and timely solutions for product selection, launch strategies and supply mitigating.
In SCBIO we follow this vision rigorously by leveraging technology to gauge the latest drug development and matching it to patients’ needs.
The SCBIO team consists of three divisions: The first division is to synthesize small molecule-based drug candidates based on SAR.
The second division is to evaluate the value of druggable targets and the effect and safety of candidates.
The third division is focusing on providing technological solutions to enhance smart business decisions.
TEL +82-42-381-1237 │ FAX +82-42-381-1232 │ Email email@example.com │ ADMIN
94-14 Techno 2-ro, Yuseong-gu, Daejeon, 34014, Korea │ Copyright ⓒ 2022 SCBIO All Rights Reserved.
TEL +82-42-381-1237 │ FAX +82-42-381-1232
Email firstname.lastname@example.org │ ADMIN
94-14 Techno 2-ro, Yuseong-gu, Daejeon, 34014, Korea
Copyright ⓒ 2022 SCBIO All Rights Reserved.